AI-Designed. Quantum-Refined. Patient-Inspired.
CuraGen AI — Advancing breakthrough treatments through AI-generated small molecules for Alzheimer’s disease, oncology & endocrinological disorders. Harnessing state-of-the-art artificial intelligence and quantum-enhanced simulation, we transform formerly intractable targets into precision-designed therapeutics.
CureRx Generator
Transformer-based generative models create vast libraries of candidate molecules tailored to a target’s binding pocket.
Bio-Digital Twin Suite
In-silico ADME/Toxicology models evaluate absorption, distribution, metabolism, excretion, and early safety, prioritising compounds with favourable brain penetration for central-nervous-system indications.
Physics & Quantum Refinement
GPU molecular-dynamics and quantum-enhanced calculations rank candidates by binding free energy and conformational stability.
About Computer-Aided Drug Discovery (CADD)
Modern drug discovery is no longer driven solely by trial-and-error chemistry. CADD leverages high-performance computing to (1) predict three-dimensional protein structures, (2) screen millions of virtual compounds against those structures, and (3) design novel molecules with optimal potency, safety, and pharmacokinetic profiles before any material is synthesized in the laboratory. Generative AI extends this capability by learning chemical “grammar” from large reaction databases and proposing entirely new, drug-like scaffolds in seconds. Quantum-accelerated physics engines now further refine binding-energy calculations, providing sub-kcal mol⁻¹ accuracy that shortens optimisation cycles and lowers pre-clinical attrition.
Our Vision
"We envisage a future in which a diagnosis of Alzheimer’s disease or aggressive cancer leads not to uncertainty, but to a rapid, precision-engineered therapeutic solution delivered through data-driven science."
Engage With CuraGen AI
Investors – We are raising seed capital to advance our first Alzheimer’s lead into IND-enabling studies.
Industry Partners – Collaborate with us to integrate our generative-design stack into your discovery workflow or to licence bespoke AI-designed compounds.
Academic Networks – Combine your biological insights with our computational platform to accelerate target validation and lead identification.
For inquiries, please contact info@curagen.ai.